Product lifecycle solutions
We deliver intelligent insights through the pharmaceutical product lifecycle
From early-stage commercial opportunity assessment and market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and post-launch tracking, we can support pharma with intelligent market research and consulting solutions through the lifecycle of the brand.
Senior level involvement
Our large, senior team of over 40 Directors are involved at every stage of the project.
High quality research
Our outputs answer the key business questions with a clear, direct recommendation, supported by the research evidence.
Communication and flexibility
We keep clients informed through weekly updates and respond quickly to needs and deadlines.
A creative approach
We offer custom approaches, not branded solutions, so our research design is always creative and fresh.
- Some example case studiesHow we conducted ethnography research to enhance new product development
The challengeThe majority of stoma patients in developing emerging markets such as India and Indonesia use external bags that are domestically manufactured or imported. We conducted research which gave internal stakeholders the necessary direction for developing a new product concept. The solutionEthnography research in the form of participant observations was conducted with 10 patients in each market who had a permanent colostomy procedure. The ethnography…read more »How we used ethnography to capture behavioural insights
The challengeHaemophilia A & B markets are highly competitive and cluttered where HCPs and patients perceive similar efficacy and safety across available products. Our client wanted to inform the design of an improved infusion device to differentiate and deliver a better experience. The challenge was to identify deeper insights from behavioural observation (beyond claimed/ stated experience) to differentiate user experience across various devices and identify…read more »How we helped our client to evaluate early biosimilar user experience
The challenge: Our client wanted to evaluate early user experience for physicians and patients across Europe of a newly launched biosimilar in an autoimmune disease. The results were needed to better understand drivers and barriers of prescribing/using biosimilars (vs. biologics) and suitable patient types to develop more targeted communication material. The solution: We opted for qualitative telephone interviews to reach a dispersed and small target…read more »
- Our latest white papersThe impact of COVID-19 on chronic disease management and the implications for pharma marketing
On February 11, 2020, COVID-19 was officially named by the World Health Organisation (WHO). Since then the novel coronavirus causing it, (a severe acute respiratory syndrome) has left its mark on almost every country in the world.read more »China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.read more »